Whereas this evidence suggests that depleted or enriched TFAM parallels changes in mtDNA and might be specific of certain cancer types, further investigation is needed to evaluate the influence of TFAM mutations in HCC development and progression. The gene discussed is TFAM; the disease is hepatocellular carcinoma.